Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Yasuda

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome]Shinsuke Yasuda
Internal Medicine (Tokyo, Japan)|January 16, 2013
Disseminated intravascular coagulation in the presence of antiphospholipid antibodies: the differential diagnosis from catastrophic or microangiopathic antiphospholipid syndromeShinsuke Yasuda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 10, 2014
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome]Shinsuke Yasuda
Internal Medicine (Tokyo, Japan)|March 18, 2016
Antiphospholipid Antibodies as a Thrombotic Risk Factor in Connective Tissue Diseases and Idiopathic/immune Thrombocytopenic Purpura--Proposal for Altered Cut-off values for Better PredictionShinsuke Yasuda
Modern Rheumatology|June 28, 2018
Emerging targets for the treatment of lupus erythematosus: There is no royal road to treating lupusShinsuke Yasuda
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis.]Shinsuke Yasuda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 24, 2004
[Antiphospholipid syndrome]Shinsuke Yasuda, Takao Koike
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: VIII. Polymyalgia Rheumatica]Shinsuke Yasuda, Tetsuya Horita
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2006
[New insights into the pathogenicity of antiphospholipid antibodies]Shinsuke Yasuda, Takao Koike
Rheumatology (Oxford, England)|November 5, 2024
Cyclin dependent kinase inhibitor: a long-awaited, late-coming, novel class agent in rheumatoid arthritisTadashi Hosoya, Tetsuya Saito, Shinsuke Yasuda
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 1, 2005
[Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome]Shinsuke Yasuda
Internal Medicine (Tokyo, Japan)|January 16, 2013
Disseminated intravascular coagulation in the presence of antiphospholipid antibodies: the differential diagnosis from catastrophic or microangiopathic antiphospholipid syndromeShinsuke Yasuda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 10, 2014
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 2. Antiphospholipid syndrome]Shinsuke Yasuda
Internal Medicine (Tokyo, Japan)|March 18, 2016
Antiphospholipid Antibodies as a Thrombotic Risk Factor in Connective Tissue Diseases and Idiopathic/immune Thrombocytopenic Purpura--Proposal for Altered Cut-off values for Better PredictionShinsuke Yasuda
Modern Rheumatology|June 28, 2018
Emerging targets for the treatment of lupus erythematosus: There is no royal road to treating lupusShinsuke Yasuda
Clinical Calcium|May 8, 2018
[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis.]Shinsuke Yasuda
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 24, 2004
[Antiphospholipid syndrome]Shinsuke Yasuda, Takao Koike
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 31, 2018
[Diagnostic (Classification) Criteria and Treatment Guidelines of Collagen-vascular Diseases: Hos to Use and Cautions on Applying Them for General Physicians. Topics: VIII. Polymyalgia Rheumatica]Shinsuke Yasuda, Tetsuya Horita
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2006
[New insights into the pathogenicity of antiphospholipid antibodies]Shinsuke Yasuda, Takao Koike
Rheumatology (Oxford, England)|November 5, 2024
Cyclin dependent kinase inhibitor: a long-awaited, late-coming, novel class agent in rheumatoid arthritisTadashi Hosoya, Tetsuya Saito, Shinsuke Yasuda
Pageof 18